Literature DB >> 29881770

Characteristics and Predictors of Intention to use Cessation Treatment among Smokers with Schizophrenia: Young Adults Compared to Older Adults.

Mary F Brunette1, Joelle C Feiron1, Kelly Aschbrenner1, Daniel Colctti2, Timothy Devitt3, Mary Ann Greene1, Amy Harrington4, Gregory C MoHugo1, Samh Pratt1, Delbert Robinson2, Jill Williams5, Haiyi Xie1.   

Abstract

BACKGROUND: Over half of young adults with schizophrenia smoke. Quitting before age 30 could prevent some of the disparate morbidity and mortality due to smoking-related diseases. However, little research has addressed smoking in this group nor evaluated strategies to help young adults with schizophrenia quit smoking.
METHODS: We compared demographic and smoking-related characteristics of young adults and those over 30 years of age among 184 smokers with schizophrenia. With a series of regression models, we assessed whether age, gender, smoking characteristics, social norms, attitudes, and perceived behavioral control predicted intention to quit smoking and to use cessation treatments.
RESULTS: Young adults had smoked for fewer years, had lower nicotine dependence, and had lower breath carbon monoxide levels than those over 30, yet awareness of the harms of smoking and readiness to quit were similar between groups. Attitudes about smoking, attitudes about cessation treatment, social norms for cessation treatment, and perceived behavioral control for cessation treatment significantly predicted intention to use cessation treatment. Age was not a predictor of intention to quit, nor to use cessation treatment.
CONCLUSIONS: Young adults with schizophrenia are amenable to smoking cessation intervention. Increasing awareness of the safety, efficacy and access to cessation treatments among smokers with schizophrenia and also among those in their social network may improve use of effective cessation treatment. These strategies may enhance the standard educational approach (increasing awareness of harms). Research is needed to evaluate such intervention strategies in smokers with schizophrenia of all ages.

Entities:  

Keywords:  Cessation treatment; Schizophrenia; Smoking; Tobacco; Young adult

Year:  2017        PMID: 29881770      PMCID: PMC5988490     

Source DB:  PubMed          Journal:  J Subst Abus Alcohol        ISSN: 2373-9363


  43 in total

1.  The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change.

Authors:  C C DiClemente; J O Prochaska; S K Fairhurst; W F Velicer; M M Velasquez; J S Rossi
Journal:  J Consult Clin Psychol       Date:  1991-04

2.  Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.

Authors:  Joelle C Ferron; Timothy Devitt; Gregory J McHugo; Jessica A Jonikas; Judith A Cook; Mary F Brunette
Journal:  Community Ment Health J       Date:  2016-03-01

3.  Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus.

Authors:  Youn O Lee; Christine J Hebert; James M Nonnemaker; Annice E Kim
Journal:  Prev Med       Date:  2014-01-16       Impact factor: 4.018

4.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors:  K O Fagerström
Journal:  Addict Behav       Date:  1978       Impact factor: 3.913

5.  A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Authors:  Jill M Williams; Robert M Anthenelli; Chad D Morris; Joan Treadow; John R Thompson; Carla Yunis; Tony P George
Journal:  J Clin Psychiatry       Date:  2012-05       Impact factor: 4.384

6.  Smoking and mental illness in the U.S. population.

Authors:  Philip H Smith; Carolyn M Mazure; Sherry A McKee
Journal:  Tob Control       Date:  2014-04-12       Impact factor: 7.552

7.  National and state prevalence of smoke-free rules in homes with and without children and smokers: Two decades of progress.

Authors:  Brian A King; Roshni Patel; Stephen D Babb; Anne M Hartman; Alison Freeman
Journal:  Prev Med       Date:  2015-11-18       Impact factor: 4.018

8.  Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up.

Authors:  Niloofar Taghizadeh; Judith M Vonk; H Marike Boezen
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

Review 9.  Smoking cessation and reduction in people with chronic mental illness.

Authors:  Jennifer W Tidey; Mollie E Miller
Journal:  BMJ       Date:  2015-09-21

10.  Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Authors:  Robert M Anthenelli; Neal L Benowitz; Robert West; Lisa St Aubin; Thomas McRae; David Lawrence; John Ascher; Cristina Russ; Alok Krishen; A Eden Evins
Journal:  Lancet       Date:  2016-04-22       Impact factor: 79.321

View more
  7 in total

1.  Attitudes about smoking cessation treatment, intention to quit, and cessation treatment utilization among young adult smokers with severe mental illnesses.

Authors:  Mary F Brunette; Joelle C Ferron; Kelly A Aschbrenner; Sarah I Pratt; Pamela Geiger; Samuel Kosydar
Journal:  Addict Behav       Date:  2018-09-25       Impact factor: 3.913

2.  Brief Web-Based Interventions for Young Adult Smokers With Severe Mental Illnesses: A Randomized, Controlled Pilot Study.

Authors:  Mary F Brunette; Joelle C Ferron; Delbert Robinson; Daniel Coletti; Pamela Geiger; Timothy Devitt; Vanessa Klodnick; Jennifer Gottlieb; Haiyi Xie; Mary Ann Greene; Douglas Ziedonis; Robert E Drake; Gregory J McHugo
Journal:  Nicotine Tob Res       Date:  2018-09-04       Impact factor: 4.244

3.  Workshop on the Development and Evaluation of Digital Therapeutics for Health Behavior Change: Science, Methods, and Projects.

Authors:  Alan J Budney; Lisa A Marsch; Will M Aklin; Jacob T Borodovsky; Mary F Brunette; Andrew T Campbell; Jesse Dallery; David Kotz; Ashley A Knapp; Sarah E Lord; Edward V Nunes; Emily A Scherer; Catherine Stanger; William C Torrey
Journal:  JMIR Ment Health       Date:  2020-02-26

4.  Brief, Web-Based Interventions to Motivate Smokers With Schizophrenia: Randomized Trial.

Authors:  Mary F Brunette; Joelle C Ferron; Susan R McGurk; Jill M Williams; Amy Harrington; Timothy Devitt; Haiyi Xie
Journal:  JMIR Ment Health       Date:  2020-02-08

5.  Is there an association between perceived social support and cardiovascular health behaviours in people with severe mental illnesses?

Authors:  Alexandra Burton; Kate Walters; Louise Marston; David Osborn
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-05-18       Impact factor: 4.328

6.  A Systematic Review of Psychosocial Barriers and Facilitators to Smoking Cessation in People Living With Schizophrenia.

Authors:  Alistair Lum; Eliza Skelton; Olivia Wynne; Billie Bonevski
Journal:  Front Psychiatry       Date:  2018-11-06       Impact factor: 4.157

7.  Perceptions of Mobile Apps for Smoking Cessation Among Young People in Community Mental Health Care: Qualitative Study.

Authors:  Minda A Gowarty; Nathan J Kung; Ashley E Maher; Meghan R Longacre; Mary F Brunette
Journal:  JMIR Form Res       Date:  2020-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.